Impressum / Imprint

Datenschutzerklaerung / Statement on Data Protection

First-in-kind anticancer therapy combining light-controllable cytotoxic peptides and dendritic cell-based immunotherapy

Back to Projects
Quick Info

2026 - 2029

Cross-Thematic

Research Project

101234442

Funder Info
Funding Information

EU Research and Innovation programme

Participating Organizations
Organization Website
Taras Shevchenko National University of Kyiv
National Cancer Institute State Non-profit Enterprise
Bienta Limited Company